On-Demand Webinar - Driving Better Titers and Shorter Timelines with a Robust and Scalable CHO DG44 Platform 

Watch this on-demand webinar held on October 06, 2022, to learn more about the challenges for developing new generation vectors and effective process improvements to increase the utility of CHO DG44 as a cell line development platform. 

In this webinar, Dr. Sufia Karim, Director, Cell Line Development, Aragen Life Sciences will highlight on:

  • Challenges faced while using the dihydrofolate reductase (DHFR)-deficient CHO DG44 platform
  • New generation vectors and process design improvements to improve CHO DG44 as a cell line development platform

Speaker

Dr. Sufia Karim
Director Cell Line Development
Aragen Life Sciences
Please fill the form to see the webinar
FIRST NAME
LAST NAME
EMAIL
COMPANY
COUNTRY
MESSAGE
By submitting this form you agree to our Privacy Policy concerning the way Aragen may use your personal information.